Home » Topics » Regulatory

Regulatory
RSS

FDA approves Varubi for nausea and vomiting associated with cancer chemotherapy

Sep. 3, 2015

Kanuma becomes first approved treatment in E.U. for LAL-D

Sep. 1, 2015

ALK's house dust mite allergy immunotherapy approved in 11 European countries

Sep. 1, 2015

FDA approves Aptiom as monotherapy for partial-onset seizures

Aug. 31, 2015

Exelixis receives first regulatory approval of cobimetinib in Switzerland

Aug. 28, 2015

Tracleer approved in Japan for new digital ulcers in patients with systemic scleroderma

Aug. 26, 2015

Remicade approved in Japan for entero-Behcet's, neuro-Behcet's and vasculo-Behcet's disease

Aug. 25, 2015

Daiichi Sankyo announces Japanese approvals for supplementary indications

Aug. 25, 2015

FDA approves first treatment for hypoactive sexual desire disorder in women

Aug. 19, 2015

FDA approves Keveyis for primary hyperkalemic and hypokalemic periodic paralysis

Aug. 11, 2015

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...